# Shanghai Yizhong Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-yizhong-pharmaceutical-co

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.yizhongpharma.com
- Latest round: Series B (Aug 1, 2018)
- Investors on record: 3

## About

Based in Shanghai, China and established in 2009, Shanghai Yizhong Pharmaceutical Co., Ltd. is a pharmaceutical company that focuses on the development of new dosage forms of anti-tumor drugs and related products. In 2021, the company was listed on the Shanghai Stock Exchange.

The company engages in the development of new dosage forms of anti-tumor drugs and related products. Its main product is paclitaxel polymer micelles for injection. Paclitaxel polymer micelles for injection is a lyophilized preparation of paclitaxel nano-micelle particles with 1.1 types of pharmaceutical excipients as a carrier, which is used in the treatment of malignant tumors.

## Funding rounds

- Series B, Aug 1, 2018 — Addor Capital, Shengduo Jinji
- Series A, Sep 22, 2017 — Hankang Capital

## Investors

- Hankang Capital (https://capitalatlas.ai/funds/hankang-capital) — Series A
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series B
- Shengduo Jinji — Series B